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MATERIALS AND METHODS
Small fragments of frozen lyophilized epidermis
were incubated with about 20 l reaction mixture
containing a buffer (mostly 0.1 M tris pH 72, in
rare cases 0.05 M phosphate pH 7.1), the radio-
active substrate, other substrates, and activators
or inhibitors. The radioactive products were:
adenine-8-'4C, hypoxanthine-84C, xanthine-8-°4C,
guanine-8-14C hydrochloride, uric aeid-2-'4C, ura-
cil-2-°4C, thymine-2-14C, thymidine-2-14C, eytosine-
2-14C and orotie acid-6-'4C. All were 98% or more
ehromatographically homogenous, except for xan-
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thine, which contained 5% impurity, and for uric
acid, which consisted of 3 main components.
The reaction was stopped after 1—2 hours in-
cubation at 37° and the products were spotted on
Whatman 1 filter paper sheets. According to the
reaction products expected, a choice was made of
at least 2 among the following solvents, all used
in ascending direction:
1. isoamyl alcohol—5% Na2HPO4 (1:1),
2. water-saturated n-butanol,
3. distilled water,
4. 80% formic acid—n-hutanol——n-propanol—
acetone—30% trichloro-aeetic acid (5:8:4:
5:3),
5. n-butanol——4% boric acid (43:7),
6. isobutyrie acid—water—ammonia 0.880—ver-
sene 0.1 M (500:279:21:8),
7. upper phase of ethyl acetate—water—formic
acid (12:7:1),
8. t-butanol——88% formic acid—water (14:3:3).
The radioactive spots were identified by auto-
radiography on X-ray film and quantitated with a
Panax radioehromatogram scanner. Their locali-
zation was compared with that of reference sub-
stances run on the same paper.
For a few reactions, the radioactive CO2 formed
was trapped with 0.3 M KOH and counted in a
liquid scintillation counter.
RESULTS
The results of the various experiments are
summarized in Table I.
COMMENTS
The main pathway towards the formation
of purine nueleotides starts from small mole-
cules (glutamine, bicarbonate, formate, gly-
eine, aspartate, and ribose-5-phosphate) and
leads to the formation of inosine-5'-monophos-
phate. The purine nueleosides and bases are
not intermediates on that synthetic route. How-
ever, numerous enzymatic reactions have been
described involving the synthesis, interconver-
sion, and breakdown of bases, nucleosides, and
nueleotides. Some of these reactions are re-
garded as salvage pathways permitting re-
utilization of purines. The breakdown reactions
lead to uric acid, the common metabolic prod-
uct of purines. These various reactions are
given schematically in Fig. 1.
The synthesis of pyrimidine nueleotides
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The continuous cellular renewal occurring in
the epidermis requires a very active synthesis
and breakdown of nuclear and cytoplasmie
nucleic acids. Data on the enzyme systems
participating in these metabolic processes are
rather fragmentary (1—9) and some are, in
terms of biochemical time, in need of up-
dating. In some other publications (10—18),
the presence and concentration of various in-
termediate products is given.
In this paper, we tried to collect and supple-
ment these data by investigating the presence
or absence in epidermis of enzyme systems
that have been described in other tissues.
This first investigation was a qualitative one,
and some limitations were set by practical
considerations. Also we cannot be certain that
the results are valid for every type of epider-
mis, most experiments having been performed
with normal plantar epidermis and with pso-
riatic and tumoral tissue. It will be seen that
the results were qualitatively comparable.
Quantitatively, higher activities were some-
times found in psoriatie epidermis or scales.
Because crude tissue was used, the simulta-
neous occurrence of several reactions and the
influence of inhibitors cannot be ruled out.
Hence, a negative result does not establish an
absolute value.
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TABLE I'
Radioactive
substrate
Other sobstratea,
activators Buffer
Radioactive producta
identified Solventa
H Tris H 3,5
X Tris X 1,3
UA Tris UA(?) 1, 4
T NADPH Tris 002 *
U NADPH Tris 002 *
2. A Tris,P04 A,H 1,6
0 Tris G,X 1,4,6
3.a A RiP Tris A, H, HIlt 1, 2, 3, 4, 5, 6
H RiP Tris H,HR 1,2,4,5,60 RiP Tris G,GR 1,2,4,5,6
X RiP Tris X,XR 1,2,4,5,6
UA RiP Tris UA(?) 1, 2, 4, 5, 6
A dRiP Tris A, H, HdR 1, 3, 4, 7
H dRiP Tris H, HdR 1, 4, 7
0 dRiP Tris 0, GdR 1, 4
X dRiP Tris X, XdR(?) 1, 4
UA dRiP Tris UA(?) 1, 4
T RiP Tris T,TH 1,2,5,7,8
U RiP Tris U,UR 1,2,5,7,8
0 RiP Tris 0 1,2,7
0 RiP Tris 0 1,7
T dRiP Tris T, TdR 4, 7
TdR P04 T, TdR 4, 7
U dRiP Tris U, UdR 1, 4, 7
0 dRiP Tris 0 1,40 dRiP Tris 0 1, 4
b A PRPP,Mg P04 A, AMP, H, 1,3,4,6,7
HR, IMPt0 PRPP, Mg P04 0, OR, GMP 1, 4, 6, 7
II PRPP,Mg P04 H,HR,IMP 1,4,6,7
X PRPP,Mg P04 X 1,4,6,7
UA PRPP,Mg P04 UA 1,6
U PRPP,Mg P04 U 1,4,6,7
T PRPP,Mg P04 T 1,4,6,7
0 PRPP,Mg P04 0 1,4,6
0 PRPP, Mg P04 0, UR, UMP 1, 3, 4, 6, 7, 8
4. TdR ATP, Mg Tris T, TdR 1, 6, 7
A RiP, ATP, Mg Tris A, H, HR 1, 6
H RiP, ATP, Mg Tris H, HR 1, 6, 80 RiP, ATP, Mg Tris G, OR 1, 6
U RiP, ATP, Mg Tris U, UR 1, 6, 7, 8
* The '00 liberated was trapped in a KOH seal and counted.
t The identity of the various products was confirmed in reaction mixtures containing hypoxanthine
or inosine as competitive inhibitors.
UA(?) As the uric acid used was quite impure, the reaction products could not be identified with
certitude; however, the pattern obtained did not appear to be different from unreaeted uric acid.
XdR(?) The identification of deoxyxanthosine in some reactions is only tentative, as tbis unstable
product was not available as a marker and no ehromatographic data were at hand.
starts from aspartate and carbamyiphosphate,
leading to the formation of orotate. The other
pyrimidine-5'-phosphates are derived from
orotidine-5'-monophosphate. Both oxidative
and reductive degradation pathways have been
described for uracil and thymine, but only
the latter is thought to be of importance in
animals, The various reactions involving py-
rimidines are given schematically in Fig, 2.
The enzymes responsible for the reactions
shown in Fig. 1 and 2 can be divided into
several groups:
1. Oxidoreductases
Xanthine oxidase catalyzes the oxidation of
hypoxanthine to xanthine and of xanthinc to
urate. Its presence was described in rat and
guinea pig skin (1, 4, 9); it was not found in
human epidermis (1, 7), a result confirmed in
the present experiments. Urate oxidase cata-
lyzes the oxidation of uric acid to allantoin. It
was not found in human epidermis.
The presence of IMP-dehydrogenase was not
investigated. The reductive degradation of
uracil and thyminc leads first to the formation
of a dihydrodcrivative and further of f9-alanine
or /3-amino-isobutyric acid, ammonia and
CO,. The latter originates from the number 2
carbon atom of the pyrimidine ring. The re-
action proceeds much faster in the presence of
NADPH. In these conditions, radioactive CO2
was recovered from uracil- and thymine-2-14C
incubated with epidermis; the reaction, how-
ever, was not very active.
2. Hydrolases acting on C—N bonds, other
than peptide bonds
Adenine and guanine deanñnases act on
adenine and guanine, yielding respectively hy-
poxanthine and xanthine.
Adenine deaminase is absent from rat skin
(3), bnt present in human epidermis (7, 8).
In our experiments deamination of adenine
occurred very rapidly. Guanine deaminase was
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—+: reactions found in the present experiments.
—s: reactions described in other tissues, not found in the present experiments.
—-+: reactions described in other tissues, not studied in the present experiments.
1 Abbreviations used in Table I and Figures 1
and 2.
A: adenine; H: hypoxanthine; G: guanine; X:
xanthine; UA: uric acid; All: allantoin; C:
cytosine; U: uracil; 0: orotic acid.
AR: adenosine; HR: inosine; etc.
AdR: deoxyadenosine; HdR: dcoxyinosine; etc.
AMP: adenosine-5'-monophosphate; IMP: mo-
sine-5'-monophosphate; etc.
dAMP: dcoxyadenosine - 5' - monophosphate;
dGMP: deoxyguanosinc-5'-monophosphatc; etc.
RiP: ribose-1-phosphatc, dRiP: deoxyribosc-1-
phosphate; NADPH: reduced nicotinamide-
adenine dinucleotide phosphate; Tris: tris(hy-
droxymethyl)aminomethane-HC1 buffer; P04:
phosphate buffer.
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described in rat skin (3); it was also present
in human epidermis. Adenosine deaminase was
not studied in the present experiments, but its
presence in psoriatie scales and rat skin was
demonstrated earlier by means of paper chro-
matography and differential spectrophotometry
of unlabeled compounds (2, 5). It was not
certain whether a guanosine deaminase was
also present in rat skin. The observed forma-
tion of xanthine from guanosine could be ex-
plained by a pathway involving first the forma-
tion of guanine (2).
The presence of AMP-deaminase was not
investigated.
Cytosine deaminase was not present.
3. Trcnsf erases transferring pentose groups
a) Nucleosidoses—Furine nucleoside phos-
phorylase catalyzes the equilibrium between a
nucleoside + inorganic phosphate and the cor-
responding purine base + ribose- or deoxyri-
bose-i-phosphate. The equilibrium favors the
synthesis of the nueleoside. This reaction, al-
ready mentioned or studied in previous papers
(5, 6), occurred with hypoxanthine, guanine,
and xanthine, giving both ribonucleosides and
deoxyribonucleosides. Inosine and deoxyinosine
were formed from adenine, after a preliminary
deamination to hypoxanthine; adenine nucleo-
sides were not found. As far as could be ascer-
tained, no reaction occurred with uric acid.
Thymine and uracil reacted with deoxyribose-
1-phosphate to yield thymidine (5) and deoxy-
uridine, with ribose-i-phosphate to yield thy-
mine riboside and uridine. The responsible
enzyme is thought to be different from purine
nucleoside phosphorylase. No synthetic reac-
tion was found when starting with cytosine or
orotie acid.
Nucleoside hydrolases were not detected. If
an apparent transribosidase reaction took place
when a base was incubated with a nucleoside,
the probability was strongly in favor of the
action of the phosphorylase.
b) Pyrophosphorylases.—Enzymes yielding
directly ribonucleotides from a base and phos-
phoribosylpyrophosphate play an important
part in the salvage of nucleic acid bases; they
are thought to be specific for the respective
bases. The presence of this class of enzymes was
described in epidermis by Schwarz (7, 8), who
detected adenylie and guanylie nucleotides
after incubation with adenine-'4C. Nucleotides
were not formed from hypoxanthine-'4C. In our
experiments the corresponding nucleotides
were synthetized from adenine, guanine, hy-
poxanthine, and orotic acid; with the latter
substrate the radioactive product formed was
identified as uridine-5'-monophosphoric acid,
whose mobility it had in 6 different solvents.
No reaction was found with xanthine and nra-
cil. Enzymes for cytosine, thymine, and uric
acid are not known in other tissues and were
not found.
4. Transf erases transferring phosphate groups
Nueleoside phosphokinases catalyze the for-
mation of a nucleotide from its nucleoside and
require the participation of ATP. They have
been described for adenosine, guanosine, mo-
sine, uridine, and thymidine. In the present
experiments, and except for the use of thymi-
dine-'4C, they could only be studied indirectly,
coupled with the action of the nueleoside phos-
phorylase, in a system containing the radioac-
tive base, ribose-i-phosphate, and ATP. With
neither substrate was nucleotide formation dem-
onstrated.
These results are at variance from those of
authors who found incorporation of labeled
thymidine into nuclear DNA in vivo; the dis-
crepancy is probably due to the different ex-
perimental conditions.
5. Hydrola.ses acting on phosphoric
monoesters
The presence of acid phosphatase in epider-
mis is well known; this enzyme also catalyzes
transphosphorylations. Neutral 5'-nucleotidase
is apparently absent from epidermis. The ac-
tivity of these enzymes could not be revealed
directly in the present experiments, but they
were probably responsible for the appearance
of the nucleoside in a reaction mixture con-
taining a base (hypoxanthine, guanine, orotic
acid) and phosphoribosylpyrophosphate.
The numerous reactions involving mono-, di-
and trinucleotides were outside the scope of
this paper.
Our experiments demonstrate the presence in
human epidermis of a fairly complete array of
enzyme systems for the metabolism of purine
and some pyrimidine bases and nucleosides.
However, some enzymes are apparently lacking.
It is too early to speculate on the significance
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of these findings, particularly in view of the
fact that our in vitro systems may not cor-
respond to the situation in vivo, and that the
enzyme activities used for the cellular metabo-
lism are not known. Further quantitation of
these activities and of the various intermedi-
ate products is needed to elucidate these prob-
lems more fully.
SUMMARY
The enzymes of purine and pyrimidine base
and nuclcoside metabolism present in human
epidermis were studied in in vitro systems.
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